Lawrence S Olanoff - Net Worth and Insider Trading
Lawrence S Olanoff Net Worth
The estimated net worth of Lawrence S Olanoff is at least $302,311 dollars as of 2024-11-13. Lawrence S Olanoff is the Director of Ironwood Pharmaceuticals Inc and owns about 68,629 shares of Ironwood Pharmaceuticals Inc (IRWD) stock worth over $302,311. Details can be seen in Lawrence S Olanoff's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Lawrence S Olanoff has not made any transactions after 2020-06-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Lawrence S Olanoff
Lawrence S Olanoff Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Lawrence S Olanoff owns 3 companies in total, including Ironwood Pharmaceuticals Inc (IRWD) , Sio Gene Therapies Inc (SIOX) , and Imunon Inc (IMNN) .
Click here to see the complete history of Lawrence S Olanoff’s form 4 insider trades.
Insider Ownership Summary of Lawrence S Olanoff
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
IRWD | Ironwood Pharmaceuticals Inc | 2020-06-10 | director |
SIOX | Sio Gene Therapies Inc | 2015-06-10 | director |
IMNN | Imunon Inc | 2006-03-15 | President & CEO |
Lawrence S Olanoff Latest Holdings Summary
Lawrence S Olanoff currently owns a total of 1 stock. Lawrence S Olanoff owns 68,629 shares of Ironwood Pharmaceuticals Inc (IRWD) as of June 10, 2020, with a value of $302,311.
Latest Holdings of Lawrence S Olanoff
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
IRWD | Ironwood Pharmaceuticals Inc | 2020-06-10 | 68,629 | 4.41 | 302,311 |
Holding Weightings of Lawrence S Olanoff
Lawrence S Olanoff Form 4 Trading Tracker
According to the SEC Form 4 filings, Lawrence S Olanoff has made a total of 1 transactions in Ironwood Pharmaceuticals Inc (IRWD) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Ironwood Pharmaceuticals Inc is the sale of 11,350 shares on June 10, 2020, which brought Lawrence S Olanoff around $114,181.
Insider Trading History of Lawrence S Olanoff
- 1
Lawrence S Olanoff Trading Performance
Lawrence S Olanoff Ownership Network
Ownership Network List of Lawrence S Olanoff
Ownership Network Relation of Lawrence S Olanoff
Lawrence S Olanoff Owned Company Details
What does Ironwood Pharmaceuticals Inc do?
Who are the key executives at Ironwood Pharmaceuticals Inc?
Lawrence S Olanoff is the director of Ironwood Pharmaceuticals Inc. Other key executives at Ironwood Pharmaceuticals Inc include Principal Accounting Officer Ronald Silver , Chief Legal Officer Minardo John , and SVP & Chief Business Officer Andrew Davis .
Ironwood Pharmaceuticals Inc (IRWD) Insider Trades Summary
Over the past 18 months, Lawrence S Olanoff made no insider transaction in Ironwood Pharmaceuticals Inc (IRWD). Other recent insider transactions involving Ironwood Pharmaceuticals Inc (IRWD) include a net sale of 307,414 shares made by Thomas A Mccourt , a net sale of 81,739 shares made by Minardo John , and a net sale of 42,163 shares made by Andrew Davis .
In summary, during the past 3 months, insiders sold 0 shares of Ironwood Pharmaceuticals Inc (IRWD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 622,069 shares of Ironwood Pharmaceuticals Inc (IRWD) were sold and 53,676 shares were bought by its insiders, resulting in a net sale of 568,393 shares.
Ironwood Pharmaceuticals Inc (IRWD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ironwood Pharmaceuticals Inc Insider Transactions
Lawrence S Olanoff Mailing Address
Above is the net worth, insider trading, and ownership report for Lawrence S Olanoff. You might contact Lawrence S Olanoff via mailing address: C/o Ironwood Pharmaceuticals, Inc., 100 Summer Street, Suite 2300, Boston Ma 02110.